[PDF][PDF] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the …

J Boren, MJ Chapman, RM Krauss… - European heart …, 2020 - academic.oup.com
OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …

Coronary artery calcification: from mechanism to molecular imaging

T Nakahara, MR Dweck, N Narula, D Pisapia… - JACC: Cardiovascular …, 2017 - jacc.org
Vascular calcification is a hallmark of atherosclerosis. The location, density, and confluence
of calcification may change portions of the arterial conduit to a noncompliant structure …

[HTML][HTML] Calcific aortic valve disease: not simply a degenerative process a review and agenda for research from the National Heart and Lung and Blood Institute Aortic …

NM Rajamannan, FJ Evans, E Aikawa… - Circulation, 2011 - ncbi.nlm.nih.gov
Calcific aortic valve disease (CAVD) encompasses the range of disease from initial
alterations in the cell biology of the leaflets to end-stage calcification resulting in left …

2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of …

RO Bonow, BA Carabello, K Chatterjee… - Journal of the American …, 2008 - jacc.org
The ACC and the AHA have long been involved in the joint development of practice
guidelines designed to assist healthcare providers in the management of selected …

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association …

RO Bonow, BA Carabello, K Chatterjee… - Journal of the American …, 2006 - jacc.org
The ACC and the AHA have long been involved in the joint development of practice
guidelines designed to assist healthcare providers in the management of selected …

Vascular calcification: pathobiology of a multifaceted disease

LL Demer, Y Tintut - Circulation, 2008 - Am Heart Assoc
with the matrix and with the periodicity of negative charges on collagen. Crystals initially
form octacalcium phosphate [Ca8H2 (PO4) 6· 5H2O], which reorganizes and seeds epitaxial …

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

RV Freeman, CM Otto - Circulation, 2005 - Am Heart Assoc
ACE has been identified in aortic sclerotic lesions. 13 Although there is evidence that some
ACE may be produced locally, the majority was extracellular and colocalized with …

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

SJ Cowell, DE Newby, RJ Prescott… - … England Journal of …, 2005 - Mass Medical Soc
Background Calcific aortic stenosis has many characteristics in common with
atherosclerosis, including hypercholesterolemia. We hypothesized that intensive lipid …

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

DJ Graham, JA Staffa, D Shatin, SE Andrade… - Jama, 2004 - jamanetwork.com
ContextLipid-lowering agents are widely prescribed in the United States. Reliable estimates
of rhabdomyolysis risk with various lipid-lowering agents are not available. ObjectiveTo …

Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery

MA Rogers, E Aikawa - Nature Reviews Cardiology, 2019 - nature.com
Cardiovascular calcification is a health disorder with increasing prevalence and high
morbidity and mortality. The only available therapeutic options for calcific vascular and …